Literature DB >> 20585414

The Design and Synthesis of Highly Branched and Spherically Symmetric Fluorinated Macrocyclic Chelators.

Zhong-Xing Jiang1, Y Bruce Yu.   

Abstract

Two novel, highly fluorinated macrocyclic chelators with highly branched and spherically symmetric fluorocarbon moieties have been designed and efficiently synthesized. This is achieved by conjugating a spherically symmetric fluorocarbon moiety to the macrocyclic chelator DOTA, with or without a flexible oligo-oxyethylene linker between these two parts. As a result of the spherical symmetry, all 27 fluorine atoms in each fluorinated chelator give a sharp singlet (19)F NMR signal. The hydrophilicity and the (19)F relaxation behavior of fluorinated chelators can be modulated by the insertion of a flexible linker between the fluorocarbon moiety and the macrocyclic linker. These chelators serve as prototypes for (1)H-(19)F dual-nuclei magnetic resonance imaging agents.

Entities:  

Year:  2008        PMID: 20585414      PMCID: PMC2888522          DOI: 10.1055/s-2007-1000857

Source DB:  PubMed          Journal:  Synthesis (Stuttg)        ISSN: 0039-7881            Impact factor:   3.157


  7 in total

Review 1.  Physics and instrumentation for imaging in-vivo drug distribution.

Authors:  M Singh; V Waluch
Journal:  Adv Drug Deliv Rev       Date:  2000-03-15       Impact factor: 15.470

2.  The synthesis of a geminally perfluoro-tert-butylated beta-amino acid and its protected forms as a potential pharmacokinetic modulator and reporter for peptide-based pharmaceuticals.

Authors:  Zhong-Xing Jiang; Y Bruce Yu
Journal:  J Org Chem       Date:  2007-01-23       Impact factor: 4.354

3.  DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy.

Authors:  A Otte; E Jermann; M Behe; M Goetze; H C Bucher; H W Roser; A Heppeler; J Mueller-Brand; H R Maecke
Journal:  Eur J Nucl Med       Date:  1997-07

Review 4.  OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy.

Authors:  M C Smith; J Liu; T Chen; H Schran; C M Yeh; F Jamar; R Valkema; W Bakker; L Kvols; E Krenning; S Pauwels
Journal:  Digestion       Date:  2000       Impact factor: 3.216

5.  Fluorocarbon nanoparticles as multifunctional drug delivery vehicles.

Authors:  Y Bruce Yu
Journal:  J Drug Target       Date:  2006-12       Impact factor: 5.121

6.  19F Magnetic resonance imaging of perfluorooctanoic acid encapsulated in liposome for biodistribution measurement.

Authors:  Atsuomi Kimura; Michiko Narazaki; Yoko Kanazawa; Hideaki Fujiwara
Journal:  Magn Reson Imaging       Date:  2004-07       Impact factor: 2.546

7.  The Design and Synthesis of Highly Branched and Spherically Symmetric Fluorinated Oils and Amphiles.

Authors:  Zhong-Xing Jiang; Y Bruce Yu
Journal:  Tetrahedron       Date:  2007-05-07       Impact factor: 2.457

  7 in total
  5 in total

1.  Fluorous mixture synthesis of asymmetric dendrimers.

Authors:  Zhong-Xing Jiang; Yihua Bruce Yu
Journal:  J Org Chem       Date:  2010-03-19       Impact factor: 4.354

2.  Synthesis and characterization of perfluoro-tert-butyl semifluorinated amphiphilic polymers and their potential application in hydrophobic drug delivery.

Authors:  Sarah Decato; Troy Bemis; Eric Madsen; Sandro Mecozzi
Journal:  Polym Chem       Date:  2014-11-21       Impact factor: 5.582

3.  Fluorinated paramagnetic chelates as potential multi-chromic 19F tracer agents.

Authors:  Zhong-Xing Jiang; Yue Feng; Yihua Bruce Yu
Journal:  Chem Commun (Camb)       Date:  2011-05-26       Impact factor: 6.222

4.  Symmetry-guided design and fluorous synthesis of a stable and rapidly excreted imaging tracer for (19)F MRI.

Authors:  Zhong-Xing Jiang; Xin Liu; Eun-Kee Jeong; Yihua Bruce Yu
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

5.  An improved synthesis of a fluorophosphonate-polyethylene glycol-biotin probe and its use against competitive substrates.

Authors:  Hao Xu; Hairat Sabit; Gordon L Amidon; H D Hollis Showalter
Journal:  Beilstein J Org Chem       Date:  2013-01-15       Impact factor: 2.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.